Not yet recruiting
Breast cancer
Not yet recruitingRadium-223 dichloride (223RaCl) with drug combination for patients with symptomatic bone metastases from breast cancer
Registered drugNo placebo
Radium-223 dichloride (223RaCl) with drug combination for patients with symptomatic bone metastases from breast cancer
Registered drugNo placebo
- Disease:Breast cancer
- Substances:AnastrozoleExemestane+1
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:Anastrozole
- Sponsor:Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone
